JP2024537607A5 - - Google Patents
Info
- Publication number
- JP2024537607A5 JP2024537607A5 JP2024513179A JP2024513179A JP2024537607A5 JP 2024537607 A5 JP2024537607 A5 JP 2024537607A5 JP 2024513179 A JP2024513179 A JP 2024513179A JP 2024513179 A JP2024513179 A JP 2024513179A JP 2024537607 A5 JP2024537607 A5 JP 2024537607A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- inhibitor
- pluripotent stem
- composition
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110989429.8 | 2021-08-26 | ||
| CN202110989429 | 2021-08-26 | ||
| CN202210654031 | 2022-06-09 | ||
| CN202210654031.3 | 2022-06-09 | ||
| PCT/CN2022/115235 WO2023025302A1 (zh) | 2021-08-26 | 2022-08-26 | 诱导全能性干细胞及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537607A JP2024537607A (ja) | 2024-10-16 |
| JP2024537607A5 true JP2024537607A5 (https=) | 2025-09-02 |
Family
ID=85292872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513179A Pending JP2024537607A (ja) | 2021-08-26 | 2022-08-26 | 誘導全能性幹細胞及びその調製方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250263669A1 (https=) |
| EP (1) | EP4394030A4 (https=) |
| JP (1) | JP2024537607A (https=) |
| CN (1) | CN115725495A (https=) |
| AR (1) | AR126901A1 (https=) |
| TW (1) | TW202328432A (https=) |
| WO (1) | WO2023025302A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116676256A (zh) * | 2023-06-07 | 2023-09-01 | 浙江大学 | 细胞快速化学重编程技术 |
| WO2025170008A1 (ja) * | 2024-02-07 | 2025-08-14 | 国立大学法人京都大学 | 成熟心筋細胞の製造方法 |
| WO2025207779A1 (en) * | 2024-03-28 | 2025-10-02 | Pioneer Hi-Bred International, Inc. | Kinase inhibitors for plant cell reprogramming |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8394630B2 (en) * | 2009-01-13 | 2013-03-12 | StemBios Technologies, Inc. | Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs) |
| US9822336B2 (en) * | 2013-04-16 | 2017-11-21 | Universiteit Maastricht | Blastoid, cell line based artificial blastocyst |
| CN104278008B (zh) * | 2013-07-12 | 2020-08-21 | 北京宏冠再生医学科技有限公司 | 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途 |
| US20170114323A1 (en) * | 2014-06-19 | 2017-04-27 | Whitehead Institute For Biomedical Research | Uses of kinase inhibitors for inducing and maintaining pluripotency |
| CN106554936B (zh) * | 2015-09-30 | 2020-05-05 | 海门雨霖细胞科技有限责任公司 | 诱导人干细胞向肝细胞定向分化的新方法 |
| US20190282624A1 (en) * | 2015-11-30 | 2019-09-19 | Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. | Improved methods for reprograming non-pluripotent cells into pluripotent stem cells |
| US12018278B2 (en) * | 2017-05-31 | 2024-06-25 | Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. | Methods for chemically induced lineage reprogramming |
| JP7474520B2 (ja) * | 2019-04-05 | 2024-04-25 | ザ・ユニバーシティ・オブ・ホンコン | 哺乳類の拡大ポテンシャル幹細胞のための培地、その組成物および方法 |
-
2022
- 2022-08-25 TW TW111132108A patent/TW202328432A/zh unknown
- 2022-08-26 EP EP22860648.9A patent/EP4394030A4/en active Pending
- 2022-08-26 JP JP2024513179A patent/JP2024537607A/ja active Pending
- 2022-08-26 US US18/686,799 patent/US20250263669A1/en active Pending
- 2022-08-26 CN CN202211033084.XA patent/CN115725495A/zh active Pending
- 2022-08-26 AR ARP220102319A patent/AR126901A1/es not_active Application Discontinuation
- 2022-08-26 WO PCT/CN2022/115235 patent/WO2023025302A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024537607A5 (https=) | ||
| Ryall et al. | Metabolic reprogramming of stem cell epigenetics | |
| Srirattana et al. | Strategies to improve the efficiency of somatic cell nuclear transfer | |
| Harvey et al. | Interplay between metabolites and the epigenome in regulating embryonic and adult stem cell potency and maintenance | |
| Coker et al. | The epigenetic role of vitamin C in neurodevelopment | |
| Jung et al. | Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming | |
| Kilberg et al. | Influence of amino acid metabolism on embryonic stem cell function and differentiation | |
| Li et al. | Chemical approaches to stem cell biology and therapeutics | |
| JP7055740B2 (ja) | 多能性幹細胞由来膵前駆細胞の純化法とその増幅法 | |
| JP2016535601A5 (https=) | ||
| JP2015165823A5 (https=) | ||
| JP7445268B2 (ja) | 未分化維持培地添加剤 | |
| EP3260536B1 (en) | Novel method for inducing chondrocyte | |
| Douvaras et al. | Epigenetic modulation of human induced pluripotent stem cell differentiation to oligodendrocytes | |
| Han et al. | Epigenetic landscape of pluripotent stem cells | |
| Su et al. | Gene expression profiling elucidates a specific role for RARγ in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells | |
| Simmet et al. | Manipulating the epigenome in nuclear transfer cloning: Where, when and how | |
| Zhang et al. | Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells | |
| D’Aniello et al. | Metabolic–epigenetic axis in pluripotent state transitions | |
| Vougiouklakis et al. | Critical roles of protein methyltransferases and demethylases in the regulation of embryonic stem cell fate | |
| JP7506746B2 (ja) | 腸管上皮細胞の製造方法、及びその利用 | |
| WO2023025302A1 (zh) | 诱导全能性干细胞及其制备方法 | |
| JP2016202172A (ja) | 疑似膵島の製造方法 | |
| Huang et al. | Epigenetic modulations of induced pluripotent stem cells: novel therapies and disease models | |
| Bhute et al. | Advances in applications of metabolomics in pluripotent stem cell research |